ARTIDIS AG is a clinical stage medical technology company developing the first nanotechnology platform for tissue analysis combined with a digital data platform, intended for broad use in drug discovery, tissue engineering as well as for rapid diagnostics and personalized treatment optimization.
$27M sweet spot round size
2018
$27M
from investors over 1 rounds
ARTIDIS raised $27M on July 1, 2023